000 01398 a2200409 4500
005 20250517145856.0
264 0 _c20171020
008 201710s 0 0 eng d
022 _a1532-6535
024 7 _a10.1002/cpt.700
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrishna, R
245 0 0 _aChronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cNov 2017
300 _a832-840 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdipose Tissue
_xdrug effects
650 0 4 _aAdult
650 0 4 _aAnticholesteremic Agents
_xadministration & dosage
650 0 4 _aCholesterol Ester Transfer Proteins
_xantagonists & inhibitors
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOxazolidinones
_xadministration & dosage
700 1 _aGheyas, F
700 1 _aLiu, Y
700 1 _aHagen, D R
700 1 _aWalker, B
700 1 _aChawla, A
700 1 _aCote, J
700 1 _aBlaustein, R O
700 1 _aGutstein, D E
773 0 _tClinical pharmacology and therapeutics
_gvol. 102
_gno. 5
_gp. 832-840
856 4 0 _uhttps://doi.org/10.1002/cpt.700
_zAvailable from publisher's website
999 _c27052843
_d27052843